NFXL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.346200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.978200E-01
Normal-vs-Stage2
9.538800E-01
Normal-vs-Stage3
4.792200E-02
Normal-vs-Stage4
9.308200E-01
Stage1-vs-Stage2
2.595600E-01
Stage1-vs-Stage3
5.901700E-03
Stage1-vs-Stage4
4.029400E-01
Stage2-vs-Stage3
5.762000E-02
Stage2-vs-Stage4
9.660400E-01
Stage3-vs-Stage4
1.055010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.452800E-01
Normal-vs-AfricanAmerican
4.572400E-01
Normal-vs-Asian
7.719600E-01
Caucasian-vs-AfricanAmerican
1.448250E-01
Caucasian-vs-Asian
5.446600E-01
AfricanAmerican-vs-Asian
1.424770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.144600E-01
Normal-vs-Female
9.499400E-01
Male-vs-Female
8.963800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.958400E-01
Normal-vs-Age(41-60Yrs)
6.714400E-01
Normal-vs-Age(61-80Yrs)
9.206800E-01
Normal-vs-Age(81-100Yrs)
9.857200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.684000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.231400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.877600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.248100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.165400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.825400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.437400E-01
Normal-vs-Daily Drinker
9.166400E-01
Normal-vs-Weekly Drinker
7.695200E-01
Normal-vs-Occasional Drinker
7.958400E-01
Normal-vs-Social Drinker
7.981600E-01
Non Drinker-vs-Daily Drinker
9.624600E-01
Non Drinker-vs-Weekly Drinker
6.917000E-01
Non Drinker-vs-Occasional Drinker
5.849600E-01
Non Drinker-vs-Social Drinker
5.888200E-01
Daily Drinker-vs-Weekly Drinker
7.101800E-01
Daily Drinker-vs-Occasional Drinker
5.258200E-01
Daily Drinker-vs-Social Drinker
5.348600E-01
Weekly Drinker-vs-Occasional Drinker
3.417800E-01
Weekly Drinker-vs-Social Drinker
3.706800E-01
Occasional Drinker-vs-Social Drinker
9.554400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.666800E-01
Normal-vs-Grade 2
8.478600E-01
Normal-vs-Grade 3
4.305800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.391800E-01
Grade 1-vs-Grade 3
5.416200E-01
Grade 1-vs-Grade 4
5.666800E-01
Grade 2-vs-Grade 3
2.056800E-01
Grade 2-vs-Grade 4
8.478600E-01
Grade 3-vs-Grade 4
4.305800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.709600E-01
Normal-vs-NonDiabetic
9.207800E-01
Diabetic-vs-NonDiabetic
2.568300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.810600E-01
Normal-vs-NoPancreatitis
9.050800E-01
Pancreatitis-vs-NoPancreatitis
5.735800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.475000E-01
Normal-vs-N1
9.566200E-01
N0-vs-N1
6.484000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.202000E-01
Normal-vs-TP53-NonMutant
6.282400E-01
TP53-Mutant-vs-TP53-NonMutant
2.903000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
